Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees

The Pfizer‐BioNTech coronavirus disease 2019 (COVID‐19) vaccine has been offered to nonallergic ≥16‐year‐old Israeli adults since December 19, 2020. Data regarding factors associated with vaccine ineffectiveness are limited. The aim of this study is to assess the impact of hepatic fibrosis on the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafrir, Asher, Amer, Johnny, Hakimian, David, Milgrom, Yael, Massarwa, Muhammad, Hazou, Wadi, Imam, Ashraf, Khalaileh, Abed, Safadi, Rifaat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110948/
https://www.ncbi.nlm.nih.gov/pubmed/35147300
http://dx.doi.org/10.1002/hep4.1901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110948/
https://www.ncbi.nlm.nih.gov/pubmed/35147300
http://dx.doi.org/10.1002/hep4.1901

Ejemplares similares